Evolent Health, Inc. Revenues
Evolent Health, Inc. (EVH) reported Revenues of $556.05 million for the 3-month period ending 2023-12-31, per its 10-K filed 2024-02-23.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2024-02-23
- Evolent Health, Inc. revenues for the quarter ending 2023-12-31 was $556.05M, a 45.40% increase year-over-year.
- Evolent Health, Inc. revenues for the quarter ending 2023-09-30 was $511.01M, a 44.93% increase year-over-year.
- Evolent Health, Inc. revenues for the quarter ending 2023-06-30 was $469.14M, a 46.63% increase year-over-year.
- Evolent Health, Inc. revenues for the quarter ending 2023-03-31 was $427.69M, a 43.98% increase year-over-year.
- Evolent Health, Inc. revenues for fiscal 2021 was $907.96M, a 1.80% decline from fiscal 2020.
- Evolent Health, Inc. revenues for fiscal 2020 was $924.64M, a 34.57% increase from fiscal 2019.
- Evolent Health, Inc. revenues for fiscal 2019 was $687.12M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2023-12-31 | $556.05M 10-K · filed 2024-02-23 | $1.07B derived: sum of 2 quarters · filed 2024-02-23 | $1.54B derived: sum of 3 quarters · filed 2024-02-23 | $1.96B derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-09-30 | $511.01M 10-K · filed 2024-02-23 | $980.15M derived: sum of 2 quarters · filed 2024-02-23 | $1.41B derived: sum of 3 quarters · filed 2024-02-23 | $1.79B derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-06-30 | $469.14M 10-K · filed 2024-02-23 | $896.83M derived: sum of 2 quarters · filed 2024-02-23 | $1.28B derived: sum of 3 quarters · filed 2024-02-23 | $1.63B derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-03-31 | $427.69M 10-K · filed 2024-02-23 | $810.12M derived: sum of 2 quarters · filed 2024-02-23 | $1.16B derived: sum of 3 quarters · filed 2024-02-23 | $1.48B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-12-31 | $382.43M 10-K · filed 2024-02-23 | $735.02M derived: sum of 2 quarters · filed 2024-02-23 | $1.05B derived: sum of 3 quarters · filed 2024-02-23 | $1.35B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-09-30 | $352.58M 10-K · filed 2024-02-23 | $672.52M derived: sum of 2 quarters · filed 2024-02-23 | $969.58M derived: sum of 3 quarters · filed 2024-02-23 | $1.22B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $319.94M 10-K · filed 2024-02-23 | $617.00M derived: sum of 2 quarters · filed 2024-02-23 | $865.35M derived: sum of 3 quarters · filed 2024-02-23 | $1.09B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $297.06M 10-K · filed 2024-02-23 | $545.41M derived: sum of 2 quarters · filed 2024-02-23 | $767.89M derived: sum of 3 quarters · filed 2024-02-23 | $989.94M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $248.36M 10-K · filed 2023-02-24 | $470.83M derived: sum of 2 quarters · filed 2023-02-24 | $692.89M derived: sum of 3 quarters · filed 2023-02-24 | $907.96M 10-K · filed 2022-02-24 |
| 2021-09-30 | $222.47M 10-K · filed 2023-02-24 | $444.53M derived: sum of 2 quarters · filed 2023-02-24 | $659.60M 10-Q · filed 2021-11-04 | $906.13M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $222.06M 10-K · filed 2023-02-24 | $437.13M 10-Q · filed 2021-08-05 | $683.66M derived: sum of 3 quarters · filed 2023-02-24 | $923.24M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $215.07M 10-K · filed 2023-02-24 | $461.61M derived: sum of 2 quarters · filed 2023-02-24 | $701.18M derived: sum of 3 quarters · filed 2023-02-24 | $918.48M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $246.54M 10-K · filed 2022-02-24 | $486.11M derived: sum of 2 quarters · filed 2022-02-24 | $703.41M derived: sum of 3 quarters · filed 2022-02-24 | $924.64M 10-K · filed 2022-02-24 |
| 2020-09-30 | $239.57M 10-K · filed 2022-02-24 | $456.87M derived: sum of 2 quarters · filed 2022-02-24 | $678.10M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $217.30M 10-K · filed 2022-02-24 | $438.53M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $221.23M 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $687.12M 10-K · filed 2022-02-24 | |||
| 2018-03-31 | $139.71M 10-Q · filed 2018-05-10 | |||
| 2017-03-31 | $106.24M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |